Geron
GERN
#6671
Rank
โ‚น69.37 B
Marketcap
โ‚น108.14
Share price
-3.42%
Change (1 day)
-22.16%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -โ‚น4.48 Billion

According to Geron's latest financial reports the company's current earnings are โ‚น0.18 Billion. , an increase over its 2024 earnings that were of -โ‚น14.94 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น4.87 Billion-67.42%
2024 -โ‚น14.94 Billion-11.23%
2023 -โ‚น16.83 Billion30.22%
2022 -โ‚น12.93 Billion20.15%
2021 -โ‚น10.76 Billion50.08%
2020 -โ‚น7.17 Billion4.46%
2019 -โ‚น6.86 Billion130.68%
2018 -โ‚น2.98 Billion8.84%
2017 -โ‚น2.74 Billion-3.08%
2016 -โ‚น2.82 Billion-22080.6%
2015 โ‚น12.82 M-100.38%
2014 -โ‚น3.41 Billion-7.14%
2013 -โ‚น3.67 Billion
2011 -โ‚น8.68 Billion19.04%
2010 -โ‚น7.29 Billion8.45%
2009 -โ‚น6.73 Billion-2.51%
2008 -โ‚น6.9 Billion14.65%
2007 -โ‚น6.02 Billion32.68%
2006 -โ‚น4.54 Billion25.59%
2005 -โ‚น3.61 Billion4.36%
2004 -โ‚น3.46 Billion19.73%
2003 -โ‚น2.89 Billion-15.46%
2002 -โ‚น3.42 Billion1.94%
2001 -โ‚น3.36 Billion33.59%
2000 -โ‚น2.51 Billion27.53%
1999 -โ‚น1.97 Billion63.13%
1998 -โ‚น1.21 Billion15.6%
1997 -โ‚น1.05 Billion-10.66%
1996 -โ‚น1.17 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚น937.55 B-19,369.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚น169.75 B-3,588.90%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น6.63 Billion 36.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น11.81 B-342.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น0.91 Billion-81.34%๐Ÿ‡บ๐Ÿ‡ธ USA